Kcentra 1,000 unit vials
Ended Awarded
- Contract number
- SPE2DB25FKRMF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,296
Award facts
- Contract value 100% obligated
- $7,296.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
As a long-standing federal pharmaceutical supplier registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical participant in the Defense Logistics Agency's pharmaceutical supply chain. The company's federal contracting history demonstrates consistent success in delivering specialized pharmaceutical products, including prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. Kcentra, a vitamin K-dependent clotting factor concentrate, is a critical hemostatic agent used in military medical settings, particularly for emergency trauma care and reversal of anticoagulation therapy in combat and field medical operations.
Quick answers
Who was awarded contract SPE2DB25FKRMF?
SPE2DB25FKRMF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FKRMF worth?
The government has obligated $7,296 on SPE2DB25FKRMF.
Is contract SPE2DB25FKRMF an order under another contract?
Yes. SPE2DB25FKRMF is a delivery order under SPE2DB24D9314, an indefinite delivery contract.
Was contract SPE2DB25FKRMF competed?
The extent of competition for SPE2DB25FKRMF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award